FDA finalizes guidance for drugs and biologics containing nanomaterials
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaPharmaceuticalsPreclinical studyProduct LifecycleResearch, Design and DevelopmentRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaPharmaceuticalsPreclinical studyProduct LifecycleResearch, Design and Development